WHAT DOES IL-2 THERAPY FOR MELANOMA MEAN?

It's effectively understood that IL-2 is actually a pleiotropic cytokine positioned on the crossroads of T mobile activation and regulation. Therefore, it can be essential to engineer an IL-two molecule that is biased in direction of effector cells bearing the intermediate affinity receptor, which include naïve and memory CD8+ T cells and NK cells